Global Cancer/Tumor Profiling Market

Global Cancer/Tumor Profiling Market Size, Trends & Analysis - Forecasts to 2026 By Cancer Type (Breast Cancer, Colorectal Cancer, Prostate Cancer, Lung Cancer, Melanoma, Others), By Biomarker Type (Genomic Biomarker, Protein Biomarker), By Application (Clinical Application, Research Application), By Technology (Immunoassays, Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarrays, Mass Spectrometry, Others), By Region (North America, Europe, Asia Pacific, CSA, MEA); Vendor Landscape, End User Landscape and Company Market Share Analysis & Competitor Analysis

Category Healthcare

Format

This report was recently updated on April 12 2024 with the latest and most recent market numbers

Cancer/Tumor Profiling Market Insights

The global cancer/tumor profiling market is estimated to witness a significant CAGR during the forecast period (2020-2026). Cancer tumor profiling is seen as a necessity to enhance the sensitivity of drugs that target kinase since they are based on the genetic structure of specific tumors. The increase in demand for personalized medicine along with the increasing use of biomarkers in cancer profiling are some of the major factors driving the market growth. Moreover, increasing investments by pharmaceutical and biotechnology companies is one of the significant factors driving the market growth. However, high investments for the development of biomarkers and the shortage of skilled professionals are some of the factors hampering the market growth.

Cancer/Tumor Profiling Market Size: By Cancer Type

Based on cancer type, global cancer/tumor profiling market is segmented into breast cancer, colorectal cancer, prostate cancer, lung cancer, and melanoma, among others. The breast cancer segment is expected to hold the largest market share during the forecast period. Furthermore, the lung cancer segment is expected to grow at a high CAGR over the coming years.

Cancer/Tumor Profiling Market Size: By Technology

Based on technology, the market is segmented into immunoassays, next generation sequencing, polymerase chain reaction, in situ hybridization, microarrays, and mass spectrometry, among others. The immunoassays segment is expected to hold the largest market share during the forecast period. Such assays are regarded as a gold standard for large-scale tumor profiling because they help to calculate the existence and concentration of analytes in a sample. Moreover, next-generation sequencing is expected to grow at a high CAGR during the forecast period. This is an innovative sequencing technique that can be used to accurately sequence tumor DNA in the genomics.

Cancer/Tumor Profiling Market Size: By Application

Based on application, the market is segmented into clinical application, and research application. The research application segment is expected to hold the largest market share during the forecast period, due to rising focus on biomarker discovery for drug development and growing demand for personalized medicines attributable to developments in technologies used in precision medicine production.

Cancer/Tumor Profiling Market Size: By Biomarker Type

Based on the biomarker type, the market is segmented into a genomic biomarker, and protein biomarker. The protein biomarker segment is expected to grow at a high CAGR during the forecast period. Moreover, the genomic biomarker segment is expected to hold the largest market share during the forecast period due to the high adoption of these biomarkers during cancer detection and prognosis and in the development process for biomarkers.

Cancer/Tumor Profiling Market Size: By Region

Based on region, cancer/tumor profiling market is segmented into North America, Europe, Asia-Pacific, Central & South America, and Middle East & Africa. The North America region is expected to hold the largest market share during the forecast period, due to rapid technological advancements, and a high prevalence of cancer and increased research in oncology; are some of the factors driving the market growth. Furthermore, the Asia-Pacific region is expected to grow at a high CAGR during the forecast period due to a large number of geriatric population, increasing awareness about personalized medicines, and the increasing incidence of cancer.

Cancer/Tumor Profiling Market Share & Competitor Analysis

Some of the key players operating in the cancer/tumor profiling market include: ILLUMINA, Inc., HTG Molecular Diagnostics, Inc., Nanostring Technologies, Inc., Ribomed Biotechnologies, Inc., Helomics Corporation, Caris Life Sciences, Qiagen N.V., Neogenomics, Inc., Sysmex Corporation, Genscript Biotech Corporation, Tempus Labs, Histogene X, Guardant Health, Inc., Boreal Genomics Inc., Perthera, Agendia, Foundation Medicine, F. Hoffmann-La Roche Ltd., Hologic, Inc., and Omniseq, among others.

Please note: This is not an exhaustive list of companies profiled in the report.

In March, 2020, Illumina signed a partnership agreement with IDbyDNA to deliver NGS Infectious Disease solutions to accelerate NGS’ adoption of clinical infectious disease testing

Check the Press Release on Global Cancer/Tumor Profiling Market Report

Cancer/Tumor Profiling Market: By Cancer Type

Introduction
1. Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
Breast Cancer
1. Breast Cancer: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
Colorectal Cancer
1. Colorectal Cancer: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
Prostate Cancer
1. Prostate Cancer: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
Lung Cancer
1. Lung Cancer: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
Melanoma
1. Melanoma: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
Others
1. Others: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

Cancer/Tumor Profiling Market: By Application

Introduction
1. Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
Clinical Application
1. Clinical Application: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
  1. Diagnostics: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
  2. Screening: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
  3. Prognostics: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
  4. Monitoring & Treatment: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
Research Application
1. Research Application: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
  1. Personalized Medicines: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
  2. Biomarker Discovery: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

Cancer/Tumor Profiling Market: By Biomarker Type

Introduction
1. Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
Genomic Biomarker
1. Genomic Biomarker: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
Protein Biomarker
1. Protein Biomarker: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
Others
1. Others: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

Cancer/Tumor Profiling Market: By Technology

Introduction
1. Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
Immunoassays
1. Immunoassays: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
Next Generation Sequencing
1. Next Generation Sequencing: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
Polymerase Chain Reaction
1. Polymerase Chain Reaction: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
In Situ Hybridization
1. In Situ Hybridization: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
Microarrays
1. Microarrays: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
Mass Spectrometry
1. Mass Spectrometry: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)
Others
1. Others: Cancer/Tumor Profiling Market, 2020-2026 (USD Million)

Cancer/Tumor Profiling Market: By Region

Introduction
1. Global Cancer/Tumor Profiling Market, Regional Analysis, 2020-2026 (USD Million)
North America
1. North America Cancer/Tumor Profiling Market, Regional Analysis, 2020-2026 (USD Million)
  1. By Cancer Type
    1. North America Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
  2. By Application
    1. North America Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
  3. By Biomarker Type
    1. North America Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
  4. By Technology
    1. North America Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
  5. By Country
    1. U.S
      1. By Cancer Type
        
        U.S Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
      2. By Application
        
        U.S Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
      3. By Biomarker Type
        
        U.S Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
      4. By Technology
        
        U.S Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
    2. Canada.
      1. By Cancer Type
        
        Canada Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
      2. By Application
        
        Canada Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
      3. By Biomarker Type
        
        Canada Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
      4. By Technology
        
        Canada Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
    3. Mexico
      1. By Cancer Type
        
        Mexico Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
      2. By Application
        
        Mexico Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
      3. By Biomarker Type
        
        Mexico Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
      4. By Technology
        
        Mexico Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
Europe
1. Europe Cancer/Tumor Profiling Market, Regional Analysis, 2020-2026 (USD Million)
  1. By Cancer Type
    1. Europe Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
  2. By Application
    1. Europe Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
  3. By Biomarker Type
    1. Europe Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
  4. By Technology
    1. Europe Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
  5. By Country
    1. Germany
      1. By Cancer Type
        
        Germany Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
      2. By Application
        
        Germany Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
      3. By Biomarker Type
        
        Germany Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
      4. By Technology
        
        Germany Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
    2. UK
      1. By Cancer Type
        
        UK Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
      2. By Application
        
        UK Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
      3. By Biomarker Type
        
        UK Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
      4. By Technology
        
        UK Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
    3. France
      1. By Cancer Type
        
        France Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
      2. By Application
        
        France Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
      3. By Biomarker Type
        
        France Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
      4. By Technology
        
        France Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
    4. Italy
      1. By Cancer Type
        
        Italy Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
      2. By Application
        
        Italy Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
      3. By Biomarker Type
        
        Italy Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
      4. By Technology
        
        Italy Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
    5. Rest Of Europe
      1. By Cancer Type
        
        Rest Of Europe Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
      2. By Application
        
        Rest Of Europe Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
      3. By Biomarker Type
        
        Rest Of Europe Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
      4. By Technology
        
        Rest Of Europe Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
Asia Pacific
1. Asia Pacific Cancer/Tumor Profiling Market, Regional Analysis, 2020-2026 (USD Million)
  1. By Cancer Type
    1. Asia Pacific Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
  2. By Application
    1. Asia Pacific Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
  3. By Biomarker Type
    1. Asia Pacific Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
  4. By Technology
    1. Asia Pacific Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
  5. By Country
    1. China
      1. By Cancer Type
        
        China Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
      2. By Application
        
        China Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
      3. By Biomarker Type
        
        China Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
      4. By Technology
        
        China Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
    2. Japan
      1. By Cancer Type
        
        Japan Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
      2. By Application
        
        Japan Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
      3. By Biomarker Type
        
        Japan Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
      4. By Technology
        
        Japan Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
    3. India
      1. By Cancer Type
        
        India Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
      2. By Application
        
        India Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
      3. By Biomarker Type
        
        India Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
      4. By Technology
        
        India Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
    4. South Korea
      1. By Cancer Type
        
        South Korea Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
      2. By Application
        
        South Korea Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
      3. By Biomarker Type
        
        South Korea Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
      4. By Technology
        
        South Korea Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
Central & South America
1. Central & South America Cancer/Tumor Profiling Market, Regional Analysis, 2020-2026 (USD Million)
  1. By Cancer Type
    1. Central & South America Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
  2. By Application
    1. Central & South America Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
  3. By Biomarker Type
    1. Central & South America Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
  4. By Technology
    1. Central & South America Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
  5. By Country
    1. Brazil
      1. By Cancer Type
        
        Brazil Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
      2. By Application
        
        Brazil Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
      3. By Biomarker Type
        
        Brazil Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
      4. By Technology
        
        Brazil Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
Middle East & Africa
1. Middle East & Africa Cancer/Tumor Profiling Market, Regional Analysis, 2020-2026 (USD Million)
  1. By Cancer Type
    1. Middle East & Africa Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
  2. By Application
    1. Middle East & Africa Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
  3. By Biomarker Type
    1. Middle East & Africa Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
  4. By Technology
    1. Middle East & Africa Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
  5. By Country
    1. Saudi Arabia
      1. By Cancer Type
        
        Saudi Arabia Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
      2. By Application
        
        Saudi Arabia Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
      3. By Biomarker Type
        
        Saudi Arabia Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
      4. By Technology
        
        Saudi Arabia Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)
    2. UAE
      1. By Cancer Type
        
        UAE Cancer/Tumor Profiling Market, By Cancer Type, 2020-2026 (USD Million)
      2. By Application
        
        UAE Cancer/Tumor Profiling Market, By Application, 2020-2026 (USD Million)
      3. By Biomarker Type
        
        UAE Cancer/Tumor Profiling Market, By Biomarker Type, 2020-2026 (USD Million)
      4. By Technology
        
        UAE Cancer/Tumor Profiling Market, By Technology, 2020-2026 (USD Million)

The global Cancer/Tumor Profiling Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Cancer/Tumor Profiling Market.

Cancer/Tumor Profiling Market

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Cancer/Tumor Profiling Market

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.

Cancer/Tumor Profiling Market